simendan has been researched along with Acute Kidney Injury in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 15 (78.95) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Akcan-Arikan, A; Alexander, PMA; Shekerdemian, LS | 1 |
| Alexander, JH; Alhanti, B; Fremes, S; Goodman, SG; Heringlake, M; Jawitz, OK; Lopes, RD; Mehta, RH; Meyer, SR; Raman, V; Stafford-Smith, M; Stebbins, AS; van Diepen, S; Whitlock, R | 1 |
| Lannemyr, L; Ricksten, SE; Tholén, M | 1 |
| Cao, X; Chen, X; Huang, T; Xu, G | 1 |
| Alvaro, G; Belletti, A; Boboshko, VA; Bove, T; Brazzi, L; Calabrò, MG; Comis, M; Frassoni, S; Grigoryev, EV; Guarracino, F; Lembo, R; Likhvantsev, VV; Lomivorotov, VV; Monaco, F; Navalesi, P; Pasyuga, VV; Paternoster, G; Pisano, A; Scandroglio, AM; Zangrillo, A | 1 |
| Huo, JH; Luo, X; Qiang, H; Wang, ZQ | 1 |
| Chen, L; He, Y; Qing, X; Zhang, Y; Zhu, J | 1 |
| Castellheim, A; Keski-Nisula, J; Ricksten, SE; Romlin, BS; Suominen, PK; Synnergren, M; Thorlacius, EM; Vistnes, M; Wåhlander, H | 1 |
| Chi, YF; Hou, WM; Niu, ZZ; Sun, WY; Wu, SM | 1 |
| Altarabsheh, SE; Avery, EG; Cho, YH; Deo, SV; Hang, D; Lim, JY; Markowitz, AH; McGraw, M; Park, SJ; Rababa'h, A | 1 |
| Chen, D; Gong, J; Liu, B; Liu, M; Wang, W; Zhou, C | 1 |
| Ariza Villanueva, D; Cruz Mañas, J; Florez Vela, A; Galán Ortega, M; Guerrero Orriach, JL; Moreno Cortés, I; Ramírez Fernandez, A; Rubio Navarro, M | 1 |
| Landoni, G; Monti, G; Pisano, A | 1 |
| Alvaro, G; Amantea, B; Auci, E; Auriemma, S; Baiocchi, M; Bianchi, A; Biondi-Zoccai, G; Bove, T; Bradic, N; Buscaglia, G; Calabrò, MG; Cariello, C; Corcione, A; De Vuono, G; Fominskiy, E; Frontini, M; Galdieri, N; Gemma, M; Gianni, S; Grigoryev, E; Guarracino, F; Landoni, G; Lembo, R; Likhvantsev, V; Lipinski, MJ; Lobreglio, R; Lomivorotov, VV; Monaco, F; Pala, G; Paternoster, G; Pisano, A; Sangalli, F; Wang, CY; Zangrillo, A; Zucchetti, MC | 1 |
| Fu, S; Li, S; Xiao, Y; Xu, G | 1 |
| Eriksson, H; Leino, K; Pöyhiä, R; Ristikankare, A; Salmenperä, M; Valtonen, M | 1 |
| Bellomo, G; Caimmi, P; Grossini, E; Mary, D; Molinari, C; Pollesello, P; Vacca, G; Valente, G | 1 |
| Bouali, R; Dubois, MJ; Verdant, CL | 1 |
| Abrass, CK; Hanson, SY; Johnson, AC; Lund, S; Zager, RA | 1 |
8 review(s) available for simendan and Acute Kidney Injury
| Article | Year |
|---|---|
Comparative Efficacy of Drugs for Preventing Acute Kidney Injury after Cardiac Surgery: A Network Meta-Analysis.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Elapid Venoms; Humans; Hydrazones; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Natriuretic Peptide, C-Type; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Treatment Outcome | 2018 |
Perioperative Use of Levosimendan Improves Clinical Outcomes in Patients After Cardiac Surgery: A Systematic Review and Meta-Analysis.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Cardiovascular Agents; Drug Administration Schedule; Heart Diseases; Humans; Incidence; Intensive Care Units; Length of Stay; Perioperative Care; Renal Replacement Therapy; Respiration, Artificial; Risk Factors; Simendan; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2018 |
Levosimendan in patients with low cardiac output syndrome undergoing cardiac surgery: A systematic review and meta-analysis.
Topics: Acute Kidney Injury; Cardiac Output; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Myocardial Infarction; Odds Ratio; Placebos; Postoperative Complications; Randomized Controlled Trials as Topic; Simendan; Time Factors | 2019 |
Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis.
Topics: Acute Kidney Injury; Adult; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Incidence; Perioperative Care; Pyridazines; Randomized Controlled Trials as Topic; Simendan | 2014 |
Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis.
Topics: Acute Kidney Injury; Adult; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Databases, Bibliographic; Humans; Hydrazones; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Ventricular Dysfunction, Left | 2015 |
Levosimendan for Prevention of Acute Kidney Injury After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials.
Topics: Acute Kidney Injury; Adult; Cardiac Surgical Procedures; Humans; Hydrazones; Kidney; Outcome Assessment, Health Care; Postoperative Complications; Protective Agents; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Vasodilator Agents | 2016 |
Levosimendan: new indications and evidence for reduction in perioperative mortality?
Topics: Acute Kidney Injury; Cardiac Output; Cardiac Surgical Procedures; Cardiotonic Agents; Critical Care; Humans; Hydrazones; Perioperative Care; Perioperative Period; Postoperative Complications; Pyridazines; Simendan | 2016 |
Recent Perioperative Pharmacological Prevention of Acute Kidney Injury after Cardiac Surgery: A Narrative Review.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Dexmedetomidine; Humans; Hydrazones; Perioperative Care; Postoperative Complications; Pyridazines; Risk Factors; Simendan | 2017 |
6 trial(s) available for simendan and Acute Kidney Injury
| Article | Year |
|---|---|
Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial.
Topics: Acute Kidney Injury; Aged; Cardiac Surgical Procedures; Cardiotonic Agents; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Odds Ratio; Placebos; Postoperative Complications; Regression Analysis; Risk Factors; Simendan; Stroke Volume; Ventricular Dysfunction, Left | 2021 |
Effects of levosimendan on renal blood flow and glomerular filtration in patients with acute kidney injury after cardiac surgery: a double blind, randomized placebo-controlled study.
Topics: Acute Kidney Injury; Adult; Aged; Cardiac Surgical Procedures; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Placebos; Renal Circulation; Simendan; Statistics, Nonparametric; Sweden; Vasodilator Agents | 2021 |
Effect of Levosimendan on Renal Outcome in Cardiac Surgery Patients With Chronic Kidney Disease and Perioperative Cardiovascular Dysfunction: A Substudy of a Multicenter Randomized Trial.
Topics: Acute Kidney Injury; Aged; Brazil; Cardiac Surgical Procedures; Cardiotonic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Valve Diseases; Humans; Incidence; Italy; Male; Middle Aged; Mitral Valve; Perioperative Period; Postoperative Complications; Renal Insufficiency, Chronic; Russia; Simendan; Treatment Outcome | 2018 |
The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Creatinine; Double-Blind Method; Female; Finland; Heart Defects, Congenital; Heart Septal Defects; Heart Septal Defects, Ventricular; Humans; Infant; Male; Milrinone; Prospective Studies; Simendan; Sweden; Tetralogy of Fallot | 2019 |
A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
Topics: Acute Kidney Injury; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Double-Blind Method; Humans; Hydrazones; Infusions, Intravenous; Intensive Care Units; Intra-Aortic Balloon Pumping; Length of Stay; Postoperative Complications; Pyridazines; Respiration, Artificial; Simendan | 2016 |
Effects of levosimendan on renal function in patients undergoing coronary artery surgery.
Topics: Acetylglucosaminidase; Acute Kidney Injury; Adult; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Artery Bypass; Creatinine; Cystatin C; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hydrazones; Kidney; Male; Prospective Studies; Pyridazines; Simendan | 2012 |
5 other study(ies) available for simendan and Acute Kidney Injury
| Article | Year |
|---|---|
Another Outcome Lost to the Benefits of Levosimendan?
Topics: Acute Kidney Injury; Cardiotonic Agents; Heart Defects, Congenital; Humans; Milrinone; Simendan | 2019 |
Assessing the effect of preoperative levosimendan on renal function in patients with right ventricular dysfunction.
Topics: Acute Kidney Injury; Aged; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Female; Humans; Hydrazones; Kidney; Kidney Function Tests; Male; Middle Aged; Neuromuscular Blockade; Postoperative Complications; Preoperative Period; Pyridazines; Simendan; Ventricular Dysfunction, Right | 2017 |
Levosimendan protection against kidney ischemia/reperfusion injuries in anesthetized pigs.
Topics: Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Cell Survival; Decanoic Acids; Glucose; Hydrazones; Hydroxy Acids; KATP Channels; Kidney; Mannitol; Mitochondria; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Potassium Chloride; Procaine; Pyridazines; Reperfusion Injury; Simendan; Swine | 2012 |
15th Annual Congress of the European Society of Intensive Care Medicine, 29 September-2 October 2002, Barcelona, Spain: clinical research to improve outcome.
Topics: Acute Kidney Injury; Critical Care; Europe; Heart Failure; Humans; Hydrazones; Incidence; Intensive Care Units; Lung Volume Measurements; Outcome Assessment, Health Care; Phosphodiesterase Inhibitors; Positive-Pressure Respiration; Pyridazines; Renal Replacement Therapy; Sepsis; Simendan; Societies, Medical; Spain | 2003 |
Levosimendan protects against experimental endotoxemic acute renal failure.
Topics: Acute Kidney Injury; Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Cardiotonic Agents; Chemokine CCL2; Endotoxemia; Glyburide; Hydrazones; Inflammation; Ischemia; Kidney; Lipopolysaccharides; Male; Mesangial Cells; Mice; Nitric Oxide; Potassium Channel Blockers; Potassium Channels; Pyridazines; Simendan; Tumor Necrosis Factor-alpha | 2006 |